7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic acid

Catalog No.: 
ACSAYT320
CAS No.: 
464-78-8
Molecular Formula: 
C10H14O3
Molecular Weight: 
182.22
7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$128.00In stockIn stock
5g98%$325.00In stockIn stock
25g98%$1495.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic acid
IUPAC Name7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic acid
MDL No.MFCD00168053
Molecular FormulaC10H14O3
Molecular Weight182.22
SMILESCC1(C)C2CCC1(C(O)=O)C(=O)C2
InChI KeyWDODWBQJVMBHCO-UHFFFAOYSA-N
SynonymKetopinic acid | 464-78-8 | 7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic acid | 6994-94-1 | Bicyclo[2.2.1]heptane-1-carboxylic acid, 7,7-dimethyl-2-oxo- | (+)-Ketopic acid | NSC169208 | Bicyclo[2.2.1]heptane-1-carboxylicacid, 7,7-dimethyl-2-oxo- | ChemDiv2_000707
CAS No.464-78-8
PubChem CID297888

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSAYT320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSAYT320 route product structure diagram
    ACSAYT320464-78-8In Stock
Inquiry

2. ACSAYT320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSAYT320 route product structure diagram
    ACSAYT320464-78-8In Stock
Inquiry

3. ACSAYT320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSAYT320 route product structure diagram
    ACSAYT320464-78-8In Stock
Inquiry

Comments (0)